Ahlholm Frederick W 4

What Happened
Frederick W. Ahlholm, SVP, Chief Financial Officer and Secretary of Minerva Neurosciences (NERV), was granted derivative securities covering 680,000 shares on June 3, 2026. The filing reports an acquisition price of $0.00 per share (total reported cash paid $0). This is a grant/award (transaction code A), not a purchase or sale.

Key Details

• Transaction date: June 3, 2026; Form 4 filed June 5, 2026.
• Reported price: $0.00 per share (derivative award).
• Number of shares/units granted: 680,000 (derivative).
• Shares owned after transaction: not specified in the provided filing data.
• Footnote: The award vests 25% on June 3, 2027, then in equal quarterly installments over the following 3 years.
• Filing timeliness: Reported on June 5, 2026 for a June 3 transaction (within the typical 2-business-day Form 4 window).

Context
This was a compensation grant of derivative securities (award), so the shares are subject to vesting and are not immediately available for sale. Such grants are commonly part of executive compensation and do not by themselves indicate a buy/sell decision in the open market. The filing does not state a cash value; the vesting schedule (see footnote) determines when the grantee may acquire or realize the underlying shares.